hotspot -WSS

hotspot

author：focus 2025-09-29 16:36:12 - browse：66129

The removal of small amounts of brain tissue from desperately ill patients, done as part of a Mount Sinai research project, triggered alarm bells at the Food and Drug Administration and has raised broader questions about the scientific and ethical justification for live-brain research. Journalist and STAT contributor Katherine Eban joins “The Readout LOUD” podcast to discuss the results of a two-year investigation.

Also on this week’s episode, we discuss Novartis’ effort to acquire MorphoSys, and the latest news on Eli Lilly and Novo Nordisk’s blockbuster obesity drugs with Elaine Chen, the newest member of STAT’s biotech reporting team.

For more on what we cover, here’s STAT’s investigation into the Mount Sinai brain-tissue research project; here’s exclusive reporting on the MorphoSys drug at the center of the Novartis acquisition, and Adam Feuerstein’s take on where it might run off the rails; and here’s STAT’s reporting on Novo Nordisk and its weight loss drug Wegovy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Readout LOUD podcast: How biotech is using artificial intelligence

leisure time

WSS

Senators start work on Medicare physician payment reform

Gilead might be held responsible for not developing a drug

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Medicare threatens to cut off funding for HCA's Mission hospital

Indictment alleges Trump's ex

A disappointing year of Humira biosimilars

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What we’ve learned from the Aduhelm mess

Psychedelics group wrestles with new pharma identity

KalVista pill reduced swelling 'attacks' caused by genetic disease

United colonoscopy coverage change 'may cost lives,' doctors say

What should King Charles tell the public about his cancer?

The high cost of giving birth even with insurance

Health AI: on the border between health care and tech

Cancer drug shortages should be causing more outrage

KalVista pill reduced swelling 'attacks' caused by genetic disease

hotspot

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

What should King Charles tell the public about his cancer?

Megan Rapinoe shares emotional post following US Women's World Cup exit

Senators start work on Medicare physician payment reform

'Revelatory' study finds a smoking impact that remains after quitting

The dental labor crisis is a moment of opportunity

explore

Wikipedia

leisure time

entertainment